FDA report endorses emergency use of Moderna’s COVID-19 vaccine

The Food and Drug Administration released a report Tuesday morning supporting Moderna's request for emergency use authorization for its COVID-19 vaccine.
The announcement is big step forward in getting millions of people across the country vaccinated as the spread of the virus continues takes its toll on communities nationwide.
In its analysis, the FDA found that Modena's vaccine was safe and effective with a 95% effective rate at least two weeks after Moderna's second dose was taken.
It also found that there were some mild, but rare side effects in clinical volunteers, including fatigue and headaches.
The FDA report comes on the heels of Pfizer's vaccine rollout, which is now being given to hospital workers and at long-term care facilities across the country.
An advisory board from the Centers of Disease Control and Prevention is expected to vote on whether to give its recommendation. If that is approved, the FDA could grant Moderna emergency use authorization for its vaccine as soon as Friday.